Harvoni

Description

Harvoni,  is the newest drug against hepatitis. Effective for the treatment of chronic hepatitis C genotype 1 in patients with and without cirrhosis of the liver. The drug is effective for patients undergoing treatment for the first time and for patients with unsuccessful experience in the treatment of hepatitis C with interferon and ribavirin, as well as in cases where there is intolerance to these drugs. The drug is included in the regimen for the treatment of viral hepatitis C, which does not require the appointment of (peg)interferon and ribavirin.

Active ingredient: Ledipasvir & Sofosbuvir

Prescription medicine.